close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

Strona główna・Stock List・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Closed

SectorHealthcare

14.95 -1.84

Buy

Price update 23 sty 2026, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

14.66

Max

14.95

Key metrics

By Trading Economics

Income

28M

8.2M

Sales

351K

351K

P/E

Sector Avg

18.136

89.037

EPS

0.94

Profit margin

2,337.322

Employees

103

EBITDA

28M

9.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+46.18% upside

Dividends

By Dow Jones

Next Earnings

12 mar 2026

Market Stats

By TradingEconomics

Market Cap

11M

144M

Previous open

16.79

Previous close

14.95

News Sentiment

By Acuity

25%

75%

52 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 sty 2026, 18:41 UTC

Earnings

SLB Readies Rapid Expansion in Venezuela -- 2nd Update

DJ

Read

23 sty 2026, 22:30 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

23 sty 2026, 22:30 UTC

Market Talk

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

DJ

Read

23 sty 2026, 22:03 UTC

Earnings

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

DJ

Read

23 sty 2026, 21:52 UTC

Earnings
Acquisitions, Mergers, Takeovers

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

DJ

Read

23 sty 2026, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

23 sty 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

23 sty 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

23 sty 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

23 sty 2026, 21:39 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

DJ

Read

23 sty 2026, 21:15 UTC

Acquisitions, Mergers, Takeovers

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

DJ

Read

23 sty 2026, 21:12 UTC

Earnings

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

DJ

Read

23 sty 2026, 20:31 UTC

Earnings

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

DJ

Read

23 sty 2026, 20:12 UTC

Market Talk

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

DJ

Read

23 sty 2026, 20:07 UTC

Market Talk

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

DJ

Read

23 sty 2026, 19:36 UTC

Market Talk

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

DJ

Read

23 sty 2026, 19:30 UTC

Market Talk
Earnings

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

DJ

Read

23 sty 2026, 19:18 UTC

Market Talk

Gold and Silver Step Up to More Records -- Market Talk

DJ

Read

23 sty 2026, 19:15 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 4th Update

DJ

Read

23 sty 2026, 18:53 UTC

Market Talk

U.S. Oil Rig Count Rises By 1 to 411 -- Market Talk

DJ

Read

23 sty 2026, 18:21 UTC

Earnings

Week's Best: Schwab's Assets and Profits Keep Climbing -- Barrons.com

DJ

Read

23 sty 2026, 18:19 UTC

Market Talk

Intel Seen as Increasingly Confident on Demand -- Market Talk

DJ

Read

23 sty 2026, 17:59 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 3rd Update

DJ

Read

23 sty 2026, 17:57 UTC

Market Talk

Intel Could Sign Deals With Big Tech Players for 14A -- Market Talk

DJ

Read

23 sty 2026, 17:57 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

23 sty 2026, 17:34 UTC

Market Talk
Earnings

Intel's Supply Challenges Seen Benefiting AMD -- Market Talk

DJ

Read

23 sty 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

23 sty 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

23 sty 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

23 sty 2026, 17:13 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

DJ

Read

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

46.18% upside

12 Months Forecast

Average 22 USD  46.18%

High 22 USD

Low 22 USD

Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

52 / 352 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

100.99

↓-0.45%

A

Agilent Technologies Inc

134.88

↓-2.69%

VEEV

Veeva Systems Inc

221.76

↓-1.44%

HQY

HealthEquity Inc

84.14

↓-2.65%

NEOG

Neogen Corp

9.81

↓-1.21%
help-icon Live chat